Clinical Trial

CMTS0929 for Inflammatory Bowel Disease

Not Yet Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
This is a prospective, open-label, single-arm study to explore the safety and the efficacy of China Microbiota Transplantation System 0929 (CMTS0929) for patients with inflammatory bowel disease (IBD).
Trial Details
NCT Number NCT06844708
Lead Sponsor The Second Hospital of Nanjing Medical University
Conditions Inflammatory Bowel Disease (IBD)
Enrollment 12 participants
Start Date 2025-02-20
Primary Completion 2030-01-31 (estimated)
Study Completion 2030-07-01 (estimated)
Updated on ClinicalTrials.gov 2025-02-25